Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (17139)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2017 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Flores-Téllez TN, Villa-Treviño S, Piña-Vázquez C. Road to stemness in hepatocellular carcinoma. World J Gastroenterol 2017; 23(37): 6750-6776 [PMID: 29085221 DOI: 10.3748/wjg.v23.i37.6750] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i37/6750.htm |
| Number | Citing Articles |
| 1 |
Hon-Ping Ma, Hang-Lung Chang, Oluwaseun Adebayo Bamodu, Vijesh Kumar Yadav, Ting-Yi Huang, Alexander T. H. Wu, Chi-Tai Yeh, Shin-Han Tsai, Wei-Hwa Lee. Collagen 1A1 (COL1A1) Is a Reliable Biomarker and Putative Therapeutic Target for Hepatocellular Carcinogenesis and Metastasis. Cancers 2019; 11(6): 786 doi: 10.3390/cancers11060786
|
| 2 |
Alicia Bort, Belén G. Sánchez, Irene de Miguel, Pedro A. Mateos-Gómez, Inés Diaz-Laviada. Dysregulated lipid metabolism in hepatocellular carcinoma cancer stem cells. Molecular Biology Reports 2020; 47(4): 2635 doi: 10.1007/s11033-020-05352-3
|
| 3 |
Jiliang Feng, Dawei Zhao, Fudong Lv, Zhongyu Yuan. Epigenetic Inheritance From Normal Origin Cells Can Determine the Aggressive Biology of Tumor-Initiating Cells and Tumor Heterogeneity. Cancer Control 2022; 29 doi: 10.1177/10732748221078160
|
| 4 |
Zahra Farzaneh, Maryam Farzaneh. Herbal Medicine-derived Compounds for the Prevention and Treatment of Hepatocellular Carcinoma. Current Cancer Therapy Reviews 2022; 18(4): 230 doi: 10.2174/1573394718666220519115626
|
| 5 |
Min Xu, Shiji Fang, Jingjing Song, Minjiang Chen, Qianqian Zhang, Qiaoyou Weng, Xiaoxi Fan, Weiqian Chen, Xulu Wu, Fazong Wu, Jianfei Tu, Zhongwei Zhao, Jiansong Ji. CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance. Cell Death & Disease 2018; 9(10) doi: 10.1038/s41419-018-0974-2
|
| 6 |
Keita Kanki, Ryota Watanabe, Le Nguyen Thai, Chun-Hao Zhao, Kyoko Naito. HDAC9 Is Preferentially Expressed in Dedifferentiated Hepatocellular Carcinoma Cells and Is Involved in an Anchorage-Independent Growth. Cancers 2020; 12(10): 2734 doi: 10.3390/cancers12102734
|
| 7 |
Miaoling Tang, Meisongzhu Yang, Geyan Wu, Shuang Mo, Xingui Wu, Shuxia Zhang, Ruyuan Yu, Yameng Hu, Yingru Xu, Ziwen Li, Xinyi Liao, Jun Li, Libing Song. Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells. Cancer Research 2021; 81(14): 3835 doi: 10.1158/0008-5472.CAN-21-0436
|
| 8 |
Jianjiang Fu, Xiaorui Su, Zhihua Li, Ling Deng, Xiawei Liu, Xuancheng Feng, Juan Peng. HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence. Oncogene 2021; 40(28): 4625 doi: 10.1038/s41388-021-01863-w
|
| 9 |
Zheping Fang, Linjun Wu, Haojiang Dai, Peng Hu, Binfeng Wang, Qiuyue Han, Yongfu Xu, Shangdong Lv, Yu Zhu, Meifu Gan, Weijie Zhou, Wenlong Zhang. The role of vesicular overexpressed in cancer pro-survival protein 1 in hepatocellular carcinoma proliferation. Cancer Biomarkers 2020; 28(1): 9 doi: 10.3233/CBM-190574
|
| 10 |
Daji Yang, Ping Zhang, Ziting Yang, Guojun Hou, Ziyu Yang. miR-4461 inhibits liver cancer stem cells expansion and chemoresistance via regulating SIRT1. Carcinogenesis 2024; 45(7): 463 doi: 10.1093/carcin/bgac093
|
| 11 |
Grégory Fouquet, Constance Marié, Louison Collet, Catherine Vilpoux, Hakim Ouled-Haddou, Eric Nguyen-Khac, Jagadeesh Bayry, Mickaël Naassila, Ingrid Marcq, Hicham Bouhlal. Rescuing SLAMF3 Expression Restores Sorafenib Response in Hepatocellular Carcinoma Cells through the Induction of Mesenchymal-to-Epithelial Transition. Cancers 2022; 14(4): 910 doi: 10.3390/cancers14040910
|
| 12 |
Kensuke Harada, Ryuya Ohashi, Kyoko Naito, Keita Kanki. Hedgehog Signal Inhibitor GANT61 Inhibits the Malignant Behavior of Undifferentiated Hepatocellular Carcinoma Cells by Targeting Non-Canonical GLI Signaling. International Journal of Molecular Sciences 2020; 21(9): 3126 doi: 10.3390/ijms21093126
|
| 13 |
Hsi-Lung Hsieh, Ming-Chin Yu, Li-Ching Cheng, Ta-Sen Yeh, Ming-Ming Tsai. Molecular mechanism of therapeutic approaches for human gastric cancer stem cells. World Journal of Stem Cells 2022; 14(1): 76-91 doi: 10.4252/wjsc.v14.i1.76
|
| 14 |
Daniel Wai-Hung Ho, Yu-Man Tsui, Karen Man-Fong Sze, Lo-Kong Chan, Tan-To Cheung, Eva Lee, Pak-Chung Sham, Stephen Kwok-Wing Tsui, Terence Kin-Wah Lee, Irene Oi-Lin Ng. Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer. Cancer Letters 2019; 459: 176 doi: 10.1016/j.canlet.2019.06.002
|
| 15 |
Marius Farcas, Andrei-Alexandru Gavrea, Diana Gulei, Calin Ionescu, Alexandru Irimie, Cristina S. Catana, Ioana Berindan-Neagoe. SIRT1 in the Development and Treatment of Hepatocellular Carcinoma. Frontiers in Nutrition 2019; 6 doi: 10.3389/fnut.2019.00148
|
| 16 |
Cong He, Doulathunnisa Jaffar Ali, Smilin Bell Aseervatham G, Bo Sun, Zhongdang Xiao. Microvesicles – promising tiny players’ of cancer stem cells targeted liver cancer treatments: The interesting interactions and therapeutic aspects. Pharmacological Research 2021; 169: 105609 doi: 10.1016/j.phrs.2021.105609
|
| 17 |
Francesca Agriesti, Tiziana Tataranni, Consiglia Pacelli, Rosella Scrima, Ilaria Laurenzana, Vitalba Ruggieri, Olga Cela, Carmela Mazzoccoli, Monica Salerno, Francesco Sessa, Gabriele Sani, Cristoforo Pomara, Nazzareno Capitanio, Claudia Piccoli. Nandrolone induces a stem cell-like phenotype in human hepatocarcinoma-derived cell line inhibiting mitochondrial respiratory activity. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58871-1
|
| 18 |
Ritu Shrestha, Kim R. Bridle, Lu Cao, Darrell H. G. Crawford, Aparna Jayachandran. Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells. Current Oncology 2021; 28(3): 2150 doi: 10.3390/curroncol28030200
|
| 19 |
Vincenzo Zara, Graziana Assalve, Alessandra Ferramosca. Insights into the malfunctioning of the mitochondrial citrate carrier: Implications for cell pathology. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2023; 1869(6): 166758 doi: 10.1016/j.bbadis.2023.166758
|
| 20 |
Wenjie Zhang, Wenlong Wu, Qiang Meng, Long Yang, Juzheng Yuan, Zelin Tian, Rui Ding, Xuan Zhang, Jianlin Wang, Kaishan Tao. Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.907399
|
| 21 |
Mingjun Tan, Rami Mosaoa, Garrett T. Graham, Anna Kasprzyk-Pawelec, Shreyas Gadre, Erika Parasido, Olga Catalina-Rodriguez, Patricia Foley, Giuseppe Giaccone, Amrita Cheema, Bhaskar Kallakury, Chris Albanese, Chunling Yi, Maria Laura Avantaggiati. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death & Differentiation 2020; 27(7): 2143 doi: 10.1038/s41418-020-0491-6
|
| 22 |
Xiangye Liu, Wenhua Shan, Tingting Li, Xiaoge Gao, Fanyun Kong, Hongjuan You, Delong Kong, Shuxi Qiao, Renxian Tang. Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08967-2
|
| 23 |
Sugandh Saxena, Shatrunajay Shukla, Poonam Kakkar. Berberine induced modulation of PHLPP2-Akt-MST1 kinase signaling is coupled with mitochondrial impairment and hepatoma cell death. Toxicology and Applied Pharmacology 2018; 347: 92 doi: 10.1016/j.taap.2018.03.033
|
| 24 |
Constance Marié, Grégory Fouquet, Anoïsia Courtois, Rabbind Singh Amrathlal, Nicolas Jankovsky, Hakim Ouled-Haddou, Riad Tebbakha, Hicham Bouhlal, Éric Nguyen-Khac, Mickaël Naassila, Ingrid Marcq. Mechanisms of chronic alcohol exposure-induced aggressiveness in cellular model of HCC and recovery after alcohol withdrawal. Cellular and Molecular Life Sciences 2022; 79(7) doi: 10.1007/s00018-022-04387-y
|
| 25 |
Julienne K. Muenzner, Philipp Kunze, Pablo Lindner, Sandra Polaschek, Kira Menke, Markus Eckstein, Carol I. Geppert, Pithi Chanvorachote, Tobias Baeuerle, Arndt Hartmann, Regine Schneider‐Stock. Generation and characterization of hepatocellular carcinoma cell lines with enhanced cancer stem cell potential. Journal of Cellular and Molecular Medicine 2018; 22(12): 6238 doi: 10.1111/jcmm.13911
|
| 26 |
Atsunori Tsuchiya, Masahiro Ogawa, Takayuki Watanabe, Suguru Takeuchi, Yuichi Kojima, Yusuke Watanabe, Naruhiro Kimura, Kazunao Hayashi, Junji Yokoyama, Shuji Terai. Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma. Heliyon 2019; 5(3): e01325 doi: 10.1016/j.heliyon.2019.e01325
|
| 27 |
Jie Zhang, Chaoyu Gu, Qianqian Song, Mengqi Zhu, Yuqing Xu, Mingbing Xiao, Wenjie Zheng. Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma. Cell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00488-y
|
| 28 |
Da-eun Nam, Angelina Angelucci, Dahsom Choi, Arnold Leigh, Hae Chang Seong, Young S. Hahn, J.-H. James Ou. Elevation of Plasminogen Activator Inhibitor-1 Promotes Differentiation of Cancer Stem-Like Cell State by Hepatitis C Virus Infection. Journal of Virology 2021; 95(10) doi: 10.1128/JVI.02057-20
|
| 29 |
Yafei Wu, Jigang Zhang, Xue Zhang, Heming Zhou, Gaolin Liu, Qin Li. Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00198
|
| 30 |
Hury Viridiana Hernández-Galdámez, Samia Fattel-Fazenda, Teresita N. J. Flores-Téllez, Mario Alejandro Aguilar-Chaparro, Jonathan Mendoza-García, Lidia C. Díaz-Fernández, Eunice Romo-Medina, Yesennia Sánchez-Pérez, Jaime Arellanes-Robledo, Mireya De la Garza, Saúl Villa-Treviño, Carolina Piña-Vázquez. Iron-saturated bovine lactoferrin: a promising chemopreventive agent for hepatocellular carcinoma. Food & Function 2024; 15(8): 4586 doi: 10.1039/D3FO05184F
|
| 31 |
Lin Su, Jiawen Bu, Jiahui Yu, Mila Jin, Guanliang Meng, Xudong Zhu. Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application. Clinical and Translational Medicine 2024; 14(11) doi: 10.1002/ctm2.70066
|
| 32 |
Qing Li, Tianyi Wang, Ximin Wang, XinYu Ge, Tao Yang, Wei Wang. DDX56 promotes EMT and cancer stemness via MELK-FOXM1 axis in hepatocellular carcinoma. iScience 2024; 27(6): 109827 doi: 10.1016/j.isci.2024.109827
|
| 33 |
Kenly Wuputra, Pi-Jung Hsiao, Wen-Tsan Chang, Po-Hsuan Wu, Lin-Ann Chen, Jian-Wei Huang, Wen-Lung Su, Ya-Han Yang, Deng-Chyang Wu, Kazunari K. Yokoyama, Kung-Kai Kuo. FOXM1-CD44 Signaling Is Critical for the Acquisition of Regorafenib Resistance in Human Liver Cancer Cells. International Journal of Molecular Sciences 2022; 23(14): 7782 doi: 10.3390/ijms23147782
|
| 34 |
Floriane Pez, Patricia Gifu, Davide Degli-Esposti, Nadim Fares, Anaïs Lopez, Lydie Lefrançois, Maud Michelet, Michel Rivoire, Brigitte Bancel, Bakary S. Sylla, Zdenko Herceg, Philippe Merle, Claude Caron de Fromentel. In vitro transformation of primary human hepatocytes: Epigenetic changes and stemness properties. Experimental Cell Research 2019; 384(2): 111643 doi: 10.1016/j.yexcr.2019.111643
|
| 35 |
Doris Schneller, Peter Angel. Hepatocellular Carcinoma. 2019; : 1 doi: 10.15586/hepatocellularcarcinoma.2019.ch1
|
| 36 |
Jyothi Priya Mandala, Srinivas Pittala, Gowru Srivani. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. 2020; : 51 doi: 10.1007/978-3-030-48405-7_3
|